Does epicatechin contribute to the acute vascular function effects of dark chocolate? A randomized, crossover study

Molecular Nutrition and Food Research

Volumn 60, Issue 11, 2016, Pages 2379-2386

  Dower, James I ^a,b   Geleijnse, Johanna M ^a,b   Kroon, Paul A ^c   Philo, Mark ^c   Mensink, Marco ^b   Kromhout, Daan ^b   Hollman, Peter C H ^a,b  

^a TOP INSTITUTE FOOD AND NUTRITION   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c NORWICH RESEARCH PARK   (United Kingdom)

Author keywords

Chocolate; Epicatechin; Flavan 3 ol; Randomized controlled trial; Vascular function

Indexed keywords

CATECHIN; FLAVAN-3-OL; FLAVONOID;

ADULT; BLOOD PRESSURE; CACAO; CHEMISTRY; CHOCOLATE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIETARY SUPPLEMENT; DRUG EFFECTS; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ADULT; BLOOD PRESSURE; CACAO; CATECHIN; CHOCOLATE; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; MALE;

EID: 84989216749     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600045     Document Type: Article

References (28)

1. Buitrago-Lopez, A., Sanderson, J., Johnson, L., Warnakula, S. et al., Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ 2011, 343, 7825.
2. Ried, K., Sullivan, T. R., Fakler, P., Frank, O. R. et al., Effect of cocoa on blood pressure. Cochr. Database Syst. Rev. 2012, 8, CD0088935.
3. Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A. et al., Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740–751.
4. Esser, D., Mars, M., Oosterink, E., Stalmach, A. et al., Dark chocolate consumption improves leukocyte adhesion factors and vascular function in overweight men. FASEB J. 2014, 28, 1464–1473.
5. Vlachopoulos, C., Aznaouridis, K., Alexopoulos, N., Economou, E. et al., Effect of dark chocolate on arterial function in healthy individuals. Am. J. Hypertens. 2005, 18, 785–791.
6. Grassi, D., Desideri, G., Necozione, S., Di Giosia, P. et al., Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals. J. Hypertens. 2015, 33, 294–303.
7. Ottaviani, J. I., Kwik-Uribe, C., Keen, C. L., Schroeter, H. Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. Am. J. Clin. Nutr. 2012, 95, 851–858.
8. Schroeter, H., Heiss, C., Balzer, J., Kleinbongard, P. et al., (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc. Natl. Acad. Sci. USA. 2006, 103, 1024–1029.
9. Loke, W. M., Hodgson, J. M., Proudfoot, J. M., McKinley, A. J. et al., Pure dietary flavonoids quercetin and (-)-epicatechin augment nitric oxide products and reduce endothelin-1 acutely in healthy men. Am. J. Clin. Nutr. 2008, 88, 1018–1025.
10. Dower, J. I., Geleijnse, J. M., Gijsbers, L., Zock, P. L. et al., Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: a randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015, 101, 914–921.
11. Berends, L. M., van der Velpen, V., Cassidy, A., Flavan-3-ols, theobromine, and the effects of cocoa and chocolate on cardiometabolic risk factors. Curr. Opin. Lipidol. 2015, 26, 10–19.
12. Hollands, W. J., Hart, D. J., Dainty, J. R., Hasselwander, O. et al., Bioavailability of epicatechin and effects on nitric oxide metabolites of an apple flavanol-rich extract supplemented beverage compared to a whole apple puree: a randomized, placebo-controlled, crossover trial. Mol. Nutr. Food Res. 2013, 57, 1209–1217.
13. Karamanoglu, M., O'Rourke, M. F., Avolio, A. P., Kelly, R. P., An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur. Heart J. 1993, 14, 160–167.
14. Pauca, A. L., O'Rourke, M. F., Kon, N. D., Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001, 38, 932–937.
15. Appeldoorn, M. M., Venema, D. P., Peters, T. H. F., Koenen, M. E. et al., Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J. Agric. Food Chem. 2009, 57, 7693–7699.
16. Saha, S., Hollands, W., Needs, P. W., Ostertag, L. M. et al., Human O-sulfated metabolites of (-)-epicatechin and methyl-(-)-epicatechin are poor substrates for commercial aryl-sulfatases: implications for studies concerned with quantifying epicatechin bioavailability. Pharmacol. Res. 2012, 65, 592–602.
17. Heiss, C., Keymel, S., Niesler, U., Ziemann, J. et al., Impaired progenitor cell activity in age-related endothelial dysfunction. J. Am. Coll. Cardiol. 2005, 45, 1441–1448.
18. Heiss, C., Sansone, R., Karimi, H., Krabbe, M. et al., Impact of cocoa flavanol intake on age-dependent vascular stiffness in healthy men: a randomized, controlled, double-masked trial. Age 2015, 37, 56.
19. Rodriguez-Mateos, A., Cifuentes-Gomez, T., Gonzalez-Salvador, I., Ottaviani, J. I. et al., Influence of age on the absorption, metabolism, and excretion of cocoa flavanols in healthy subjects. Mol. Nutr. Food Res. 2015, 59, 1504–1512.
20. Ottaviani, J. I., Momma, T. Y., Heiss, C., Kwik-Uribe, C. et al., The stereochemical configuration of flavanols influences the level and metabolism of flavanols in humans and their biological activity in vivo. Free Radic. Biol. Med. 2011, 50, 237–244.
21. Nicholls, S. J., Lundman, P., Harmer, J. A., Cutri, B. et al., Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. J. Am. Coll. Cardiol. 2006, 48, 715–720.
22. van Oostrom, A. J. H. H. M., Sijmonsma, T. P., Verseyden, C., Jansen, E. H. J. M. et al., Postprandial recruitment of neutrophils may contribute to endothelial dysfunction. J. Lipid Res. 2003, 44, 576–583.
23. Barbagallo, M., Dominguez, L. J., Galioto, A., Pineo, A. et al., Oral magnesium supplementation improves vascular function in elderly diabetic patients. Magnes. Res. 2010, 23, 131–137.
24. Shechter, M., Sharir, M., Paul, M. J., James, L. et al., Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000, 102, 2353–2358.
25. Cosaro, E., Bonafini, S., Montagnana, M., Danese, E. et al., Effects of magnesium supplements on blood pressure, endothelial function and metabolic parameters in healthy young men with a family history of metabolic syndrome. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 1213–1220.
26. Mortazavi, M., Moeinzadeh, F., Saadatnia, M., Shahidi, S. et al., Effect of magnesium supplementation on carotid intima-media thickness and flow-mediated dilatation among hemodialysis patients: a double-blind, randomized, placebo-controlled trial. Eur. Neurol. 2013, 69, 309–316.
27. Heiss, C., Finis, D., Kleinbongard, P., Hoffmann, A. et al., Sustained increase in flow-mediated dilation after daily intake of high-flavanol cocoa drink over 1 week. J. Cardiovasc. Pharmacol. 2007, 49, 74–80.
28. Heiss, C., Jahn, S., Taylor, M., Real, W. M. et al., Improvement of endothelial function with dietary flavanols is associated with mobilization of circulating angiogenic cells in patients with coronary artery disease. J. Am. Coll. Cardiol. 2010, 56, 218–224.